- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01466998
Menopausal Treatment Using Relaxation Exercises (MaTURE) (MaTURE)
May 5, 2014 updated by: Deborah Grady, University of California, San Francisco
Hot flashes occur in as many as two thirds of U.S. women during menopause and are severe enough to require treatment in 20%.
Although postmenopausal hormone therapy is effective in suppressing hot flashes, it is associated with increased risk for a variety of serious adverse effects.
There is an urgent need for alternative treatments that are effective, safe, and easy to use.
In this study, the investigators will compare two different types of behavioral relaxation therapies, paced respiration and music therapy, for treatment of menopausal hot flashes.
Effects on frequency of hot flashes, other symptom and quality-of-life outcomes associated with hot flashes, and physiologic measures of sympathetic/parasympathetic activity will be examined.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
123
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94115
- University of California, San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 59 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria
- Women aged 40 through 59 years at the time of screening.
- Perinenopausal or postmenopausal.
- Adequate adherence to study procedures during a 1-week run-in.
- At least 4 hot flashes per 24 hours recorded by a hot flash monitor and diary.
- Capable of understanding study procedures and giving informed consent.
- Willing to refrain from using other treatments for hot flashes during the study period.
Exclusion criteria
- Pregnant or breastfeeding in the past year.
- Current or recent use of medications known to affect hot flashes.
- Resting blood pressure less than 100/60.
- Spontaneous resting breathing rate less than 10 breaths/minute.
- Chronic medical therapy for pulmonary disease.
- Known sensitivity to adhesives.
- Cardiac pacemaker or implanted defibrillator.
- No access to a telephone.
- Plans to move out of the area or travel by airplane in ways that would interfere with the study.
- Inability to sign an informed consent, participate in interviews, or understand and complete questionnaires in English.
- Report conditions that, in the judgment of the investigators, render potential participants unlikely to follow the protocol.
- Participation in another research study involving investigational drugs or devices.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Paced Respiration
Participants will use a small, commercially-available guided-breathing device to practice breathing at a rate slower than 10 breaths per minute.
Participants will be instructed to use their devices for at least 15 minutes per day for 12 weeks.
|
Practice paced respiration 15 minutes per day for a total of 12 weeks.
|
ACTIVE_COMPARATOR: Music Therapy
Participant will use an identical appearing device, programmed to play quiet, relaxing non-rhythmic music while monitoring spontaneous breathing.
Participants will be instructed to use their devices for at least 15 minutes per day for 12 weeks.
|
Practice music therapy for 15 minutes per day for a total of 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in average daily frequency of hot flashes.
Time Frame: 4-Weeks and 12-Weeks
|
4-Weeks and 12-Weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in subjective severity of hot flashes.
Time Frame: 4-weeks and 12-weeks
|
4-weeks and 12-weeks
|
Change in sympathetic and parasympathetic autonomic nervous system tone.
Time Frame: 12 weeks
|
12 weeks
|
Change in quality-of-of life measures associated with hot flashes.
Time Frame: Weeks 4 and Weeks 12
|
Weeks 4 and Weeks 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Alison Huang, MD, MAS, University of California, San Francisco
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (ACTUAL)
April 1, 2014
Study Completion (ACTUAL)
April 1, 2014
Study Registration Dates
First Submitted
November 1, 2011
First Submitted That Met QC Criteria
November 3, 2011
First Posted (ESTIMATE)
November 8, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
May 6, 2014
Last Update Submitted That Met QC Criteria
May 5, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01AT005491 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hot Flashes
-
Mitsubishi Tanabe Pharma America Inc.CompletedMenopause Hot FlashesUnited States
-
University of California, San FranciscoCompleted
-
AmgenCompleted
-
University of California, San FranciscoCompleted
-
Alison Huang, MDNational Institute on Aging (NIA)Completed
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedTreatment of Menopausal Hot FlashesUnited States
-
Donesta BioscienceSynteractHCRCompleted
-
University of PennsylvaniaForest LaboratoriesCompleted
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedFever, Sweats, and Hot FlashesUnited States
-
Liverpool John Moores UniversityBritish Heart FoundationRecruiting
Clinical Trials on Paced Respiration
-
University of California, San FranciscoCompleted
-
University of Colorado, DenverNational Cancer Institute (NCI)CompletedHematopoietic/Lymphoid CancerUnited States
-
University of California, San FranciscoNational Institute on Aging (NIA)CompletedOveractive Bladder | Urgency Incontinence | Urgency Urinary SymptomsUnited States
-
University of PennsylvaniaCompletedPulmonary Arterial HypertensionUnited States
-
Indiana UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University of Colorado, DenverNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | Lung Cancer | Colon Cancer | Solid Tumor, AdultUnited States
-
McGill UniversityCanadian Institutes of Health Research (CIHR)UnknownSyncope, VasovagalCanada
-
Istanbul University - Cerrahpasa (IUC)RecruitingUrinary IncontinenceTurkey
-
Philips RespironicsCompletedSleep Apnea, ObstructiveUnited States